Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belimumab for Memory B-cell Mobilization in Highly Sensitized Kidney Transplant Candidates
NCT07539857Phase 2Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Apr 2026
- Primary completion
- Jan 2028
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in kidney transplant rejection, sponsored by Leiden University Medical Center. Started Apr 2026; status: recruiting.
02
Drugs
belimumab
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT07539857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07539857.